I guess I don't see why it would get canned especially in Japan. They pay millions to go through phase 2, they don't need to necessarily go through phase 3 before going to the market... I get if they then had to pay for phase 3 trials, and regrowth wasn't great. This looks to be a helpful treatment with great benefits, and the investment for sheisido has been made with phase 2 trials... why not bring it to the market?
I believe they still have to run another trial in Japan, they just get to release it before they are finished if the preliminary data is posititive. I would actually be shocked if it doesn't make it to market with Shiseido. Replicel is the one that is less certain, but I think they are likely to make it eventually after they start receiving payments from Shiseido, it could just take a long time. I don't care because I plan to fly to Japan and have this done ASAP, regardless of Replicel's timeline.